Sector stocks

Healthcare Stocks on NASDAQ

Compare NASDAQ-listed Healthcare stocks by fair value, valuation, financial health, profitability, risk, and market outlook.

Exicure Inc (XCUR)
Fair Value29.8% Upside Undervalued Market Cap9.816 M P/E-1.0x Yield0.0% HealthWeak
  NASDAQ
Femasys Inc (FEMY)
Fair Value42.1% Upside Undervalued Market Cap9.21 M P/E-0.7x Yield0.0% HealthWeak
  NASDAQ
Foghorn Therapeutics Inc (FHTX)
Fair Value9.3% Upside Fair Analyst134.5% Upside Market Cap285.3 M P/E-3.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Fulcrum Therapeutics Inc (FULC)
Fair Value9.7% Upside Fair Analyst-9.7% Downside Market Cap289.9 M P/E-3.4x Yield0.0% HealthFair
  NASDAQ
Gain Therapeutics Inc (GANX)
Fair Value10.2% Upside Fair Analyst300.0% Upside Market Cap75.071 M P/E-3.6x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
GeneDx Holdings Corp (WGS)
Fair Value-27.8% Downside Overvalued Analyst22.2% Upside Market Cap2.114 B P/E-19.6x Yield0.0% HealthFair
  NASDAQ Featured in Rapid Revenue Growth Small-Cap Stocks
GH Research PLC (GHRS)
Fair Value20.1% Upside Undervalued Analyst37.3% Upside Market Cap1.998 B P/E-35.4x Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks Small-Cap Stocks
Goodrx Holdings Inc (GDRX)
Fair Value47.4% Upside Undervalued Analyst-1.8% Downside Market Cap1.131 B P/E53.9x Yield0.0% HealthGreat
  NASDAQ Featured in Small-Cap Stocks
Gossamer Bio Inc (GOSS)
Fair Value38.5% Upside Undervalued Market Cap88.726 M P/E-0.5x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Greenwich Lifesciences Inc (GLSI)
Fair Value-22.6% Downside Overvalued Analyst296.1% Upside Market Cap210.6 M P/E-9.5x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
GRI Bio Inc (GRI)
Fair Value19.6% Upside Undervalued Market Cap2.816 M P/E-0.2x Yield0.0% HealthFair
  NASDAQ
Guardant Health Inc (GH)
Fair Value-35.0% Downside Overvalued Analyst17.3% Upside Market Cap21.443 B P/E-48.3x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Harmony Biosciences Holdings (HRMY)
Fair Value47.5% Upside Undervalued Analyst19.5% Upside Market Cap2.258 B P/E12.3x Yield0.0% HealthExcellent
  NASDAQ Featured in Rapid Revenue Growth
HCW Biologics Inc (HCWB)
Fair Value24.1% Upside Undervalued Analyst774.6% Upside Market Cap4.297 M P/E-0.2x Yield0.0% HealthFair
  NASDAQ
Health Catalyst Inc (HCAT)
Fair Value13.2% Upside Fair Analyst-3.2% Downside Market Cap168.5 M P/E-0.7x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks
High Tide Inc (HITI)
Fair Value5.7% Upside Fair Analyst105.6% Upside Market Cap198.5 M P/E-6.3x Yield0.0% HealthGood
  NASDAQ
Humacyte Inc (HUMA)
Fair Value2.7% Upside Fair Analyst181.2% Upside Market Cap192 M P/E-2.1x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Hyperfine Inc (HYPR)
Fair Value30.3% Upside Undervalued Analyst121.1% Upside Market Cap101.3 M P/E-2.8x Yield0.0% HealthFair
  NASDAQ Featured in Rapid Revenue Growth
I Mab (NBP)
Fair Value59.0% Upside Bargain Analyst387.8% Upside Market Cap190.8 M P/E-2.1x Yield0.0% HealthFair
  NASDAQ
Ideaya Biosciences Inc (IDYA)
Fair Value-6.5% Downside Fair Analyst47.1% Upside Market Cap3.484 B P/E-19.9x Yield0.0% HealthGood
  NASDAQ
IM Cannabis Corp (IMCC)
Fair Value43.9% Upside Undervalued Market Cap790.362 K P/E-0.1x Yield0.0% HealthFair
  NASDAQ
ImageneBio Inc (IMA)
Fair Value17.0% Upside Fair Analyst126.1% Upside Market Cap64.404 M P/E-1.2x Yield0.0% HealthFair
  NASDAQ
Immatics NV (IMTX)
Fair Value-17.5% Downside Fair Analyst82.9% Upside Market Cap1.282 B P/E-5.4x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Immuneering Corp (IMRX)
Fair Value23.1% Upside Undervalued Analyst329.5% Upside Market Cap284.7 M P/E-5.2x Yield0.0% HealthFair
  NASDAQ
Immunocore Holdings PLC (IMCR)
Fair Value10.9% Upside Fair Analyst91.0% Upside Market Cap1.691 B P/E-61.4x Yield0.0% HealthGood
  NASDAQ Featured in Small-Cap Stocks
Immunome Inc (IMNM)
Fair Value-18.4% Downside Overvalued Analyst40.2% Upside Market Cap2.838 B P/E-12.9x Yield0.0% HealthFair
  NASDAQ
Immunovant Inc (IMVT)
Fair Value-11.7% Downside Fair Analyst19.8% Upside Market Cap8.124 B P/E-16.0x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
In8bio Inc (INAB)
Fair Value36.1% Upside Undervalued Analyst532.0% Upside Market Cap9.454 M P/E-0.5x Yield0.0% HealthFair
  NASDAQ
Inhibikase Therapeutics Inc (IKT)
Fair Value-22.7% Downside Overvalued Analyst149.0% Upside Market Cap476.8 M P/E-9.2x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
InMed Pharmaceuticals Inc (INM)
Fair Value42.8% Upside Undervalued Market Cap6.652 M P/E-0.8x Yield0.0% HealthFair
  NASDAQ
InMode Ltd (INMD)
Fair Value45.8% Upside Undervalued Analyst0.8% Upside Market Cap883.5 M P/E10.1x Yield0.0% HealthGreat
  NASDAQ Featured in Small-Cap Stocks
INmune Bio Inc (INMB)
Fair Value-1.0% Downside Fair Analyst268.4% Upside Market Cap50.778 M P/E-1.2x Yield0.0% HealthWeak
  NASDAQ
Innate Pharma SA (IPHA)
Fair Value-3.8% Downside Fair Analyst239.0% Upside Market Cap166.4 M P/E-2.9x Yield0.0% HealthWeak
  NASDAQ
InnovAge Holding Corp (INNV)
Fair Value-17.2% Downside Fair Analyst-36.9% Downside Market Cap1.473 B P/E-129.7x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks Low-Float Small-Cap Momentum Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
Instil Bio Inc (TIL)
Fair Value24.9% Upside Undervalued Analyst-3.6% Downside Market Cap49.169 M P/E-1.0x Yield0.0% HealthFair
  NASDAQ
Intelligent Bio Solutions Inc (INBS)
Fair Value44.1% Upside Undervalued Analyst570.4% Upside Market Cap4.329 M P/E-0.4x Yield0.0% HealthWeak
  NASDAQ
Inventiva Sa (IVA)
Fair Value-22.6% Downside Overvalued Analyst215.3% Upside Market Cap1.058 B P/E-2.6x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Invivyd Inc (IVVD)
Fair Value13.4% Upside Fair Market Cap168.9 M P/E-2.3x Yield0.0% HealthFair
  NASDAQ
INVO Fertility Inc (IVF)
Fair Value4.1% Upside Fair Market Cap1.875 M P/E-0.2x Yield0.0% HealthFair
  NASDAQ
ISpecimen Inc (ISPC)
Fair Value39.6% Upside Undervalued Market Cap3.09 M P/E-0.3x Yield0.0% HealthWeak
  NASDAQ
Jade Biosciences Inc (JBIO)
Fair Value-31.4% Downside Overvalued Analyst123.6% Upside Market Cap1.267 B P/E-13.5x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Janux Therapeutics Inc (JANX)
Fair Value26.3% Upside Undervalued Analyst132.4% Upside Market Cap973.3 M P/E-8.5x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Jasper Therapeutics Inc (JSPR)
Fair Value11.9% Upside Fair Market Cap18.632 M P/E-0.3x Yield0.0% HealthWeak
  NASDAQ
Kalaris Therapeutics Inc (KLRS)
Fair Value8.5% Upside Fair Analyst346.6% Upside Market Cap102.8 M P/E-2.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Keros Therapeutics Inc (KROS)
Fair Value37.3% Upside Undervalued Analyst103.5% Upside Market Cap203.2 M P/E-2.4x Yield0.0% HealthWeak
  NASDAQ
Kodiak Sciences Inc (KOD)
Fair Value-34.1% Downside Overvalued Analyst49.0% Upside Market Cap2.678 B P/E-11.8x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Korro Bio Inc (KRRO)
Fair Value21.7% Upside Undervalued Analyst73.9% Upside Market Cap163.7 M P/E-1.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
KORU Medical Systems Inc (KRMD)
Fair Value-11.9% Downside Fair Analyst64.6% Upside Market Cap194.8 M P/E-83.2x Yield0.0% HealthGood
  NASDAQ
Kymera Therapeutics Inc (KYMR)
Fair Value-32.2% Downside Overvalued Analyst22.0% Upside Market Cap8.587 B P/E-27.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Lantern Pharma Inc (LTRN)
Fair Value5.9% Upside Fair Analyst525.0% Upside Market Cap35.087 M P/E-2.2x Yield0.0% HealthFair
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.